DKFZDeutsches Krebsforschungszentrum (German Cancer Research Center, Heidelberg, Germany)
References in periodicals archive ?
Professor Altevogt's research team at the DKFZ developed the antibodies against L1 and demonstrated their anti-tumor activities in an animal model.
Accuray will now be collaborating with two of the top luminary research institutions located in Heidelberg, DKFZ and the University of Heidelberg, per an agreement signed with the University of Heidelberg in March 2012.
The collaboration is based on recent DKFZ research indicating that the relative amounts of specific spliced viral RNA molecules (i.
About DKFZ The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) with its more than 2,500 employees is the largest biomedical research institute in Germany.
Now, an international research consortium along with DKFZ scientists have discovered seven DNA regions for which an association with an increased prostate cancer risk has now been established for the first time.
The center will operate 10 SOLiD[TM] 4 hq systems acquired by DKFZ and will initially sequence 1000 whole human cancer genomes for Germany's national contribution to the International Cancer Genome Consortium (ICGC).
The effects of a particular gene can depend on what other genes a person carries, and the new method developed by the teams of Wolfgang Huber at EMBL and Michael Boutros at DKFZ enables scientists to uncover and measure those combined effects.
Heike Allgayer, head of a Clinical Cooperation Unit of DKFZ and UMM, is an expert for those cellular processes that lead to metastasis in cancer.
The licensing agreement follows a successful two-month pilot program involving twenty chemists and biologists in four departments at DKFZ.
Kari Hemminki of DKFZ collaborated with colleagues in Sweden and the United States to carry out the largest study ever on cancer risks of people with type 2 diabetes.
Researchers of the department headed by Kari Hemminki at DKFZ have studied how high is an individual person's risk in familial prostate cancer.
This additional treatment option facilitates the further development of the treatment plan in new combinations with the long-term goal of improving the survival rate," said Professor Wolfgang Wick, Medical Director of the Department of Neurooncology at Heidelberg University Hospital and Head of the Neurooncology Unit at the DKFZ.